CA2171276A1 - Utilisation d'un antagoniste de recepteur d'interleukine-1 recombinant humain; composition renfermant cet antagoniste pour le traitement de l'arthrose - Google Patents

Utilisation d'un antagoniste de recepteur d'interleukine-1 recombinant humain; composition renfermant cet antagoniste pour le traitement de l'arthrose

Info

Publication number
CA2171276A1
CA2171276A1 CA002171276A CA2171276A CA2171276A1 CA 2171276 A1 CA2171276 A1 CA 2171276A1 CA 002171276 A CA002171276 A CA 002171276A CA 2171276 A CA2171276 A CA 2171276A CA 2171276 A1 CA2171276 A1 CA 2171276A1
Authority
CA
Canada
Prior art keywords
composition containing
receptor antagonist
human recombinant
osteoarthritis
recombinant interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002171276A
Other languages
English (en)
Other versions
CA2171276C (fr
Inventor
Jean-Pierre Pelletier
Johanne Martel-Pelletier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascentia Pharma Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002171276A priority Critical patent/CA2171276C/fr
Publication of CA2171276A1 publication Critical patent/CA2171276A1/fr
Application granted granted Critical
Publication of CA2171276C publication Critical patent/CA2171276C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
CA002171276A 1996-03-07 1996-03-07 Utilisation d'un antagoniste de recepteur d'interleukine-1 recombinant humain; composition renfermant cet antagoniste pour le traitement de l'arthrose Expired - Fee Related CA2171276C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002171276A CA2171276C (fr) 1996-03-07 1996-03-07 Utilisation d'un antagoniste de recepteur d'interleukine-1 recombinant humain; composition renfermant cet antagoniste pour le traitement de l'arthrose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002171276A CA2171276C (fr) 1996-03-07 1996-03-07 Utilisation d'un antagoniste de recepteur d'interleukine-1 recombinant humain; composition renfermant cet antagoniste pour le traitement de l'arthrose

Publications (2)

Publication Number Publication Date
CA2171276A1 true CA2171276A1 (fr) 1997-09-08
CA2171276C CA2171276C (fr) 2006-05-16

Family

ID=4157707

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002171276A Expired - Fee Related CA2171276C (fr) 1996-03-07 1996-03-07 Utilisation d'un antagoniste de recepteur d'interleukine-1 recombinant humain; composition renfermant cet antagoniste pour le traitement de l'arthrose

Country Status (1)

Country Link
CA (1) CA2171276C (fr)

Also Published As

Publication number Publication date
CA2171276C (fr) 2006-05-16

Similar Documents

Publication Publication Date Title
AU2582897A (en) Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
AU1721697A (en) Use of compositions comprising stabilized biologically effective compounds
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
AU3622997A (en) Fabric treatment composition
AU2205997A (en) Orthopedic implant
EP0956018A4 (fr) Composes d'imidazole, compositions les contenant et leur utilisation
AU1911597A (en) Surgical retractor
AU2126097A (en) Dental compounds, compositions and products
AU1694497A (en) Disinfecting compositions and processes for disinfecting surfaces
EP0637450A3 (fr) Méthode et composition pour revigorer le tissu cicatriciel.
AU4984497A (en) Germicidal composition
AU4555097A (en) Compounds with antimycotic and cytostatic effect, preparation method, agent containing these compounds and dsm 11 092
AU5066598A (en) Dithiocarbonate composition
AU4133997A (en) Pharmaceutical composition for the treatment of syndrome x of reaven
AU2823097A (en) P1, p4-dithio-p2,p3-monochlorom ethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent
AU2380595A (en) Biologically active composition
AU4217197A (en) Biologically active phosphotriester-type compounds
AU3918797A (en) Composition for the treatment of rice seeds
AU4994996A (en) Composition for the treatment of diarrhea, its use and its preparation
AU2411997A (en) Process for the preparation of an ethylene and alpha-olefin copolymer
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
CA2171276A1 (fr) Utilisation d'un antagoniste de recepteur d'interleukine-1 recombinant humain; composition renfermant cet antagoniste pour le traitement de l'arthrose
AU2593597A (en) Compositions for the diagnosis and treatment of chediak-higashi syndrome
AU6966998A (en) Composition for treating pain
AU2142197A (en) Water treatment compositions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed